PMGC Holdings Inc.
$3.32
▼
-59.14%
2026-04-21 06:36:01
pmgcholdings.com
NCM: ELAB
Explore PMGC Holdings Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$6.35 M
Current Price
$3.32
52W High / Low
$309.12 / $1.62
Stock P/E
—
Book Value
$97.11
Dividend Yield
—
ROCE
-76.42%
ROE
-1.07%
Face Value
—
EPS
$-382.61
Exp Qtr EPS
—
Sector
Healthcare
Industry
Biotechnology
Employees
32
Beta
0.71
Debt / Equity
33.75
Current Ratio
1.74
Quick Ratio
1.72
Forward P/E
—
Price / Sales
15.72
Enterprise Value
$2.13 M
EV / EBITDA
-0.3
EV / Revenue
3.6
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Turn Therapeutics Inc. | $3.38 | — | $103.07 M | — | -134.02% | -1.42% | $26.5 / $2.57 | $0.02 |
| 2. | Lyell Immunopharma, Inc. | $24.89 | — | $559.6 M | — | -69.37% | -86.98% | $45 / $7.65 | $11.68 |
| 3. | Curanex Pharmaceuticals Inc | $0.48 | — | $12.79 M | — | -37.04% | -85.25% | $9.18 / $0.26 | $0.01 |
| 4. | Alumis Inc. | $24.71 | — | $3.18 B | — | -134.01% | -86.68% | $30.6 / $2.76 | $2.88 |
| 5. | Bio Green Med Solution, Inc. | $1.19 | — | $6.54 M | 0.93% | 552.16% | -1.28% | $100.8 / $0.73 | $1.27 |
| 6. | Bicara Therapeutics Inc. | $23.47 | — | $1.57 B | — | -38.7% | -30.89% | $24.25 / $7.8 | $7.37 |
| 7. | Cognition Therapeutics, Inc. | $1.12 | — | $106.33 M | — | -70.77% | -88.59% | $3.83 / $0.22 | $0.39 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0.3 M | 0.29 M | 0 M | 0 M | -1.75 M | — |
| Operating Profit | -2.41 M | -2.19 M | -1.01 M | -1.2 M | 0.35 M | — |
| Net Profit | -2.98 M | -2.59 M | -0.56 M | -1.61 M | -1.93 M | — |
| EPS in Rs | -1.54 | -1.34 | -0.29 | -0.83 | -1 | -7,967.76 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0.59 M | 0 M | 0 M | 0.77 M |
| Operating Profit | -6.82 M | -3.66 M | -1.13 M | -1.79 M |
| Net Profit | -7.75 M | -6.25 M | -4.3 M | -1.8 M |
| EPS in Rs | -4 | -3.22 | -2.22 | -0.93 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 12.87 M | 8.99 M | 5.19 M | 1.89 M |
| Total Liabilities | 5.03 M | 2.33 M | 1.36 M | 0.76 M |
| Equity | 7.84 M | 6.66 M | 3.83 M | 1.13 M |
| Current Assets | 6.87 M | 6.05 M | 4.92 M | 1.55 M |
| Current Liabilities | 3.94 M | 1.8 M | 1.3 M | 0.59 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -5.93 M | -5.49 M | -4.56 M | -1.59 M |
| Investing CF | -2.77 M | -0.61 M | -0.01 M | -0.03 M |
| Financing CF | 10.12 M | 6.76 M | 6.74 M | 2.36 M |
| Free CF | -6.38 M | -5.96 M | -4.57 M | -1.62 M |
| Capex | -0.45 M | -0.47 M | -0.01 M | -0.04 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | -100% | — | — |
| Earnings Growth % | -45.2% | -138.94% | — | — |
| Profit Margin % | — | — | -234.94% | — |
| Operating Margin % | — | — | -233.37% | — |
| Gross Margin % | — | — | 58.37% | — |
| EBITDA Margin % | — | — | -233.74% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2026-03-10 | 1:0.166667 |
| 2026-01-06 | 1:0.25 |
| 2025-09-02 | 1:0.285 |
| 2025-03-10 | 1:0.142857 |
| 2024-11-27 | 1:0.005 |